SCHEMBL19079823

SCHEMBL19079823

O=C(CSc1nc2sc3c(c2c(=O)n1C1CC1)CCCC3)N1CCOCC1

nearest known ligand 0.78

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ CREBBP Q92793 1/20 0.78
▸ MAPK1 P28482 2/20 0.69
▸ TSHR P16473 1/20 0.69
▸ ALDH1A1 P00352 7/20 0.57
▸ NPSR1 Q6W5P4 2/20 0.57
▸ POLB P06746 3/20 0.55
▸ BLM P54132 1/20 0.55
▸ MEN1 O00255 5/20 0.54
▸ KMT2A Q03164 5/20 0.54
▸ HPGD P15428 2/20 0.54
▸ HIF1A Q16665 1/20 0.54
▸ KDM4E B2RXH2 4/20 0.54
▸ MAPT P10636 3/20 0.54
▸ L3MBTL1 Q9Y468 2/20 0.53
▸ LMNA P02545 1/20 0.51
▸ SMN1; SMN2 Q16637 2/20 0.49
▸ RECQL P46063 2/20 0.48
▸ TDP1 Q9NUW8 2/20 0.48
▸ NR4A1 P22736 1/20 0.48
▸ APEX1 P27695 1/20 0.48

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL19079825 0.90 CREBBP (0.63) CREBBPMAPK1TSHRALDH1A1NPSR1
SCHEMBL19079824 0.88 CREBBP (0.61) CREBBPMAPK1TSHRALDH1A1NPSR1
SCHEMBL19079672 0.82 TSHR (1.00) CREBBPMAPK1TSHRALDH1A1NPSR1
SCHEMBL19079709 0.81 TSHR (0.77) CREBBPMAPK1TSHRALDH1A1POLB
SCHEMBL4732712 0.81 ALDH1A1 (0.68) CREBBPALDH1A1NPSR1POLBBLM
SCHEMBL13962176 0.79 ALDH1A1 (0.68) CREBBPMAPK1TSHRALDH1A1NPSR1
SCHEMBL19079736 0.79 PDE4D (0.68) ALDH1A1NPSR1POLBMEN1KMT2A
SCHEMBL19079693 0.78 PDE4D (0.57) CREBBPALDH1A1NPSR1POLBMEN1
SCHEMBL19079754 0.76 PDE4D (0.71) CREBBPTSHRALDH1A1NPSR1POLB
SCHEMBL19079750 0.75 ALDH1A1 (0.73) TSHRALDH1A1NPSR1POLBMEN1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-10329304-B2 Compounds and methods for inhibition of hedgehog signaling and phosphodiesterase VANDERBILT UNIVERSITY (US) 2019-06-25 — — US disclosed
US-20170190717-A1 Compounds and Methods for Inhibition of Hedgehog Signaling and Phosphodiesterase VANDERBILT UNIVERSITY 2017-07-06 — — US disclosed
US-20170190717-A1 Compounds and Methods for Inhibition of Hedgehog Signaling and Phosphodiesterase VANDERBILT UNIVERSITY 2017-07-06 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-10329304-B2 Compounds and methods for inhibition of hedgehog signaling and phosphodiesterase PDE4A, PDE4B, PDE7A CREBBP 527/4885MAPK1 916/4885TSHR 3082/4885
US-20170190717-A1 Compounds and Methods for Inhibition of Hedgehog Signaling and Phosphodiesterase PDE4A, PDE4B, PDE7A CREBBP 527/4885MAPK1 916/4885TSHR 3082/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback